Your Notifications
All done, no notifications

Cost of Immunotherapy Worldwide

Costs starts from Get a Quote
Filters

The body uses a complex mechanism called the immune system to combat cancer. Proteins, organs, and cells are all involved in this process. Many of the immune system's inherent defenses are frequently circumvented by cancer, allowing cancer cells to grow.

One kind of cancer treatment is immunotherapy. It uses materials produced in a lab or by the body to strengthen the immune system and assist the body in locating and eliminating cancer cells. It is effective in treating a wide variety of cancers. It can be used either on its own or in conjunction with other cancer treatments, such as chemotherapy.

Factors affecting the cost of Immunotherapy:

CountryCostLocal_currency
United KingdomUSD 2269317927
TurkeyUSD 24973752686
SpainUSD 5993 - 108965514 - 10024
United StatesUSD 30000 - 4000030000 - 40000
SingaporeUSD 9000 - 1500012060 - 20100

Immunotherapy( cancer treatment) employs the body's immune system to find and eliminate cancer cells. The immune system normally recognizes and eliminates dangerous invaders, including malignant cells. It improves the immune system's capacity to identify and eliminate cancer cells.

This treatment can be highly effective and may help some cancer patients live longer. Medical researchers are continually developing new immunotherapy drugs to treat a broader range of cancer types.

Immunotherapy is a type of biological therapy. This treatment helps enhance the patient's immune system. Some immunotherapies are specifically designed for cancer, while others generally strengthen overall immunity.

Types:

Following are the types of Immunotherapy:

  • Checkpoint inhibitors.
  • Adoptive cell therapy (T-cell transfer therapy).
  • Monoclonal antibodies.
  • Cancer vaccines.
  • Immune system modulators.

Immunotherapy works to strengthen or reestablish the immune system's capacity to identify and combat infections, cancer cells, and other illnesses. It is frequently utilized to treat diseases such as lymphoma, lung cancer, and melanoma, particularly in cases where alternative therapies prove ineffective.

See a doctor if you have symptoms like unexplained weight loss, fatigue, persistent pain, lumps, or abnormal bleeding, which could indicate cancer. Get medical help right away if you have adverse effects or develop new symptoms while receiving cancer therapy. Immunotherapy and overall treatment success depend on early diagnosis and prompt intervention.

Your doctor may perform imaging scans, blood tests, or a biopsy to determine the type of cancer and your overall health in order to prepare you for immunotherapy. Any drugs, allergies, or autoimmune diseases should be disclosed to your medical staff. During treatment, you might also need to make arrangements for assistance with relaxation, transportation, and handling any possible side effects.

Immunotherapy include determining a patient's cancer eligibility, giving medication in IV cycles, and keeping an eye on adverse effects. Frequent follow-ups guarantee efficacy and permit modifications in response to patient reaction.

  • Evaluation Stage: Doctors assess cancer type and biomarkers to determine suitability for immunotherapy.
  • Preparation Stage: Blood tests and scans are performed; a personalised treatment plan is made.
  • Administration Stage: Immunotherapy medications are usually administered weekly via IV infusion.
  • Monitoring Stage: Patient is observed for side effects and treatment response during and after each cycle
  • Follow-up Stage: Regular check-ups and scans to assess effectiveness and adjust treatment.

  • Immune-related side effects like inflammation in organs (e.g. lungs, liver, or intestines).
  • Fatigue, fever, or chills during or after treatment
  • Skin reactions such as rashes or itching
  • Digestive issues like diarrhoea
  • Increased risk of infections

Immunotherapy provides long-lasting results by strengthening the immune system to target and eliminate cancer cells. In comparison to conventional therapies, it frequently has fewer side effects and is successful for advanced or recurrent tumours.

The goal of post-immunotherapy recovery is to control immune-related side effects such as exhaustion, inflammation, or hormonal fluctuations. Regular follow-ups are essential to monitor response and ensure long-term immune system balance.

Immunotherapy success rates vary by type, stage, and patient reaction. Various cancers have response rates of 20% to 50% or more, including melanoma, non-small cell lung cancer, and different forms of lymphoma.

Would you like some help? We are available.

Get Help
Explore Hospitals ( 91 )
Immunotherapy in SSO Cancer Hospital, Mumbai: Costs, Top Doctors, and Reviews

Mumbai, India

  • National Accreditation Board for Hospitals & Healthcare Providers (NABH)
  • SSO is a hospital that provides surgical oncology care tailored to each organ and employs experienced surgeons who work exclusively in this field. SSO has designed its surgical program to include minimally invasive techniques such as laparoscopic and robotic-assisted methods. Furthermore, SSO provides individualised treatment planning for cancers and has created a multidisciplinary team to provide comprehensive care to each cancer patient throughout the treatment process. In addition to providing an excellent surgical experience, SSO's aim is to help each patient retain as much functioning ability and aesthetic appearance post-surgery as possible. Lastly, SSO provides extensive support services, including physiotherapy, nutritional counselling, rehabilitation, and post-operative care.

Need Some Advice From Our Experts?

Request a Call Back Now!

Our team of healthcare experts would be happy to assist you

trusted Patientstrusted Patients+99
Trusted by 50000+ Patients
Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Process Involved for Immunotherapy

  • Preoperative Stage: The oncologist evaluates the patient's medical history and runs tests to determine immunotherapy eligibility and treatment targets.
  • Treatment Plan Discussion: The oncologist reviews therapy options, risks, and advantages while personalising the treatment plan.
  • Therapeutic Stage: Immunotherapy is delivered through injections, IVs, or oral drugs, such as targeted therapy and checkpoint inhibitors.
  • Postoperative Stage: Regular monitoring records tumor response and side effects, with long-term rehabilitation centered on relapse prevention.
  • Follow-up & recovery
  • Cancer (Various Types)
  • Cancer Recurrence
  • Specific Tumor Mutations or Markers
  • Cancer patients, including those suffering from melanoma, lung cancer, and breast cancer.
  • Patients with certain tumors who have not responded to standard treatments such as chemotherapy or radiation.
  • Those suffering from autoimmune illnesses or allergies may benefit from immune system stimulation.
  • Patients are in good general health.
  • Cytokine Therapy
  • Cancer Vaccines
  • Targeted Treatment: Immunotherapy is a better targeted and less toxic alternative to chemotherapy and radiation that reduces damage to healthy cells.
  • Immunotherapy offers long-term control for cancers with limited treatment options and minimal invasiveness, as most treatments can be administered outpatiently.
  • Medical Oncologist
  • Fill out the inquiry form: Fill out the form to provide us with the relevant information about your condition.
  • Consult with Our Healthcare Expert:One of our qualified specialists will contact you for a consultation
  • Receive a Detailed Treatment Plan:After examining your situation, we will provide you with a detailed treatment plan that includes expert views and cost breakdowns for various choices.
  • Choose your preferred option: Choose the treatment option that suits you the best.

Instantly Connect with our Immunotherapy Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Get Insight with our Blogs

Krispin’s Journey to Hope: Fighting Myeloma with Immunotherapy in India
Patient Stories

Krispin’s Journey to Hope: Fighting Myeloma with Immunotherapy in India

Krispin, a 62-year-old man from the Democratic Republic of the Congo, had a large nodule and persistent leg pain that were seriously impairing his mobility. After months of concern and uncertainty,

Published: 30 Sep, 2025
Updated: 16 Feb, 2026

Author

Fauzia Zeb Fatima
Fauzia Zeb Fatima

M.Pharm

4 Years of Experience

Fauzia Zeb is a distinguished medical and scientific content writer with a robust academic foundation in pharmaceutical sciences, holding a B.Pharm and M.Pharm degree from prestigious institutions, including MIT and Jamia Hamdard University. Her comprehensive expertise in pharmacology, clinical sciences, and biomedical research enables her to translate complex medical and scientific concepts into precise, evidence-based content tailored for diverse audiences. Specializing in peer-reviewed articles, clinical blog posts, and research-driven publications, she demonstrates a consistent ability to bridge the gap between advanced medical science and accessible, audience-specific communication.. View More

Reviewer

Dr Prateek Varshney
Dr Prateek Varshney

Surgical Oncologist

15 Years of Experience

Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More

Last Reviewed - January 2026